Literature DB >> 23163807

Angiogenesis-related microRNAs in colon cancer.

Liu Hong1, Yu Han, Yi Zhou, Ahuja Nita.   

Abstract

INTRODUCTION: Angiogenesis, for its fundamental role in cancer growth and metastasis, has become an appealing target in cancer therapy. A number of angiogenesis-related microRNAs (miRNAs) are under investigation and they can affect the cancerous phenotype of malignant cells. AREAS COVERED: The authors review the recent advances in angiogenesis-related miRNAs in human colon cancer. They also envisage future developments toward potential miRNA-based applications to cancer treatment. EXPERT OPINION: Angiogenesis-related miRNAs may reasonably be considered as a valuable cancer therapeutic tool. More investigations should be performed to promote therapeutic-clinical research of miRNAs in patients with colon cancer.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23163807     DOI: 10.1517/14712598.2013.727391

Source DB:  PubMed          Journal:  Expert Opin Biol Ther        ISSN: 1471-2598            Impact factor:   4.388


  11 in total

Review 1.  The roles of microRNAs related with progression and metastasis in human cancers.

Authors:  Hai-Ting Liu; Peng Gao
Journal:  Tumour Biol       Date:  2016-10-06

Review 2.  The fusion of two worlds: non-coding RNAs and extracellular vesicles--diagnostic and therapeutic implications (Review).

Authors:  Yukie Sato-Kuwabara; Sonia A Melo; Fernando A Soares; George A Calin
Journal:  Int J Oncol       Date:  2014-10-17       Impact factor: 5.650

3.  Upregulation of miRNA3195 and miRNA374b Mediates the Anti-Angiogenic Properties of Melatonin in Hypoxic PC-3 Prostate Cancer Cells.

Authors:  Eun Jung Sohn; Gunho Won; Jihyun Lee; Sangyoon Lee; Sung-Hoon Kim
Journal:  J Cancer       Date:  2015-01-01       Impact factor: 4.207

4.  miR-874 functions as a tumor suppressor by inhibiting angiogenesis through STAT3/VEGF-A pathway in gastric cancer.

Authors:  Xiaoyu Zhang; Jie Tang; Xiaofei Zhi; Kunling Xie; Weizhi Wang; Zheng Li; Yi Zhu; Li Yang; Hao Xu; Zekuan Xu
Journal:  Oncotarget       Date:  2015-01-30

5.  Cancer-associated oxidoreductase ERO1-α drives the production of VEGF via oxidative protein folding and regulating the mRNA level.

Authors:  Tsutomu Tanaka; Goro Kutomi; Toshimitsu Kajiwara; Kazuharu Kukita; Vitaly Kochin; Takayuki Kanaseki; Tomohide Tsukahara; Yoshihiko Hirohashi; Toshihiko Torigoe; Yoshiharu Okamoto; Koichi Hirata; Noriyuki Sato; Yasuaki Tamura
Journal:  Br J Cancer       Date:  2016-04-21       Impact factor: 7.640

6.  Circulating Plasma Levels of miR-20b, miR-29b and miR-155 as Predictors of Bevacizumab Efficacy in Patients with Metastatic Colorectal Cancer.

Authors:  Paola Ulivi; Matteo Canale; Alessandro Passardi; Giorgia Marisi; Martina Valgiusti; Giovanni Luca Frassineti; Daniele Calistri; Dino Amadori; Emanuela Scarpi
Journal:  Int J Mol Sci       Date:  2018-01-20       Impact factor: 5.923

7.  Tumor-suppressive microRNA-218 inhibits tumor angiogenesis via targeting the mTOR component RICTOR in prostate cancer.

Authors:  Bing Guan; Kaijie Wu; Jin Zeng; Shan Xu; Lijun Mu; Yang Gao; Ke Wang; Zhenkun Ma; Juanhua Tian; Qi Shi; Peng Guo; Xinyang Wang; Dalin He; Yuefeng Du
Journal:  Oncotarget       Date:  2017-01-31

8.  Inhibitory effect of endostar combined with radiotherapy on gastric cancer animal models.

Authors:  Qitian Chen; Ran Chen; Youhong Dong
Journal:  World J Surg Oncol       Date:  2020-07-15       Impact factor: 2.754

Review 9.  MicroRNAs and angiogenesis: a new era for the management of colorectal cancer.

Authors:  Yufei Tang; Shaoqi Zong; Hailun Zeng; Xiaofeng Ruan; Liting Yao; Susu Han; Fenggang Hou
Journal:  Cancer Cell Int       Date:  2021-04-17       Impact factor: 5.722

Review 10.  New insights into the regulatory role of microRNA in tumor angiogenesis and clinical implications.

Authors:  Ye Wang; Liya Wang; Cheng Chen; Xiaoyuan Chu
Journal:  Mol Cancer       Date:  2018-02-07       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.